Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Asset Utilization Ratio (2016 - 2026)

Integra Lifesciences Holdings' Asset Utilization Ratio history spans 16 years, with the latest figure at 0.45 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 13.51% to 0.45 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.45, a 13.51% increase, with the full-year FY2025 number at 0.43, up 3.93% from a year prior.
  • Asset Utilization Ratio hit 0.45 in Q4 2025 for Integra Lifesciences Holdings, roughly flat from 0.45 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for IART hit a ceiling of 0.45 in Q4 2025 and a floor of 0.37 in Q1 2021.
  • Historically, Asset Utilization Ratio has averaged 0.41 across 5 years, with a median of 0.41 in 2021.
  • Biggest five-year swings in Asset Utilization Ratio: fell 16.4% in 2021 and later increased 16.84% in 2025.
  • Tracing IART's Asset Utilization Ratio over 5 years: stood at 0.41 in 2021, then decreased by 0.85% to 0.4 in 2022, then rose by 1.27% to 0.41 in 2023, then fell by 3.03% to 0.4 in 2024, then grew by 13.51% to 0.45 in 2025.
  • Business Quant data shows Asset Utilization Ratio for IART at 0.45 in Q4 2025, 0.45 in Q3 2025, and 0.42 in Q2 2025.